000			01417 a2200349 4500
005			20250512033743.0
264		0	_c19860514
008			198605s 0 0 eng d
022			_a0026-0495
024	7		_a10.1016/0026-0495(86)90192-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aPfeifer, M A
245	0	0	_aClinical trials of sorbinil on nerve function. _h[electronic resource]
260			_bMetabolism: clinical and experimental _cApr 1986
300			_a78-82 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAldehyde Reductase _xantagonists & inhibitors
650	0	4	_aClinical Trials as Topic
650	0	4	_aDiabetes Mellitus, Type 1 _xdrug therapy
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDiabetic Neuropathies _xdrug therapy
650	0	4	_aDiabetic Retinopathy _xprevention & control
650	0	4	_aDouble-Blind Method
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aImidazolidines
650	0	4	_aNeural Conduction _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aRandom Allocation
773	0		_tMetabolism: clinical and experimental _gvol. 35 _gno. 4 Suppl 1 _gp. 78-82
856	4	0	_uhttps://doi.org/10.1016/0026-0495(86)90192-7 _zAvailable from publisher's website
999			_c3089014 _d3089014